Targeting cellular mRNAs translation by CRISPR-Cas9

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Liu, Yuchen ^a   Chen, Zhicong ^a   He, Anbang ^a   Zhan, Yonghao ^a   Li, Jianfa ^a   Liu, Li ^a   Wu, Hanwei ^a   Zhuang, Chengle ^a   Lin, Junhao ^a   Zhang, Qiaoxia ^a   Huang, Weiren ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SHENZHEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

APTAMER; CRISPR ASSOCIATED PROTEIN; DNA; LIGAND; MESSENGER RNA; RNA;

ANIMAL; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; CRISPR CAS SYSTEM; GENETICS; HELA CELL LINE; HUMAN; LEPORIDAE; NUCLEOTIDE SEQUENCE; PROTEIN SYNTHESIS; TUMOR CELL LINE;

ANIMALS; APTAMERS, NUCLEOTIDE; BASE SEQUENCE; CELL LINE, TUMOR; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEATS; CRISPR-ASSOCIATED PROTEINS; CRISPR-CAS SYSTEMS; DNA; HELA CELLS; HUMANS; LIGANDS; PROTEIN BIOSYNTHESIS; RABBITS; RNA; RNA, MESSENGER;

EID: 84978412112     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep29652     Document Type: Article

References (40)

1. Sternberg, S. H. & Doudna, J. A. Expanding the Biologist's Toolkit with CRISPR-Cas9. Mol Cell 58, 568-574 (2015).
2. Doudna, J. A. & Charpentier, E. Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science 346, 1258096 (2014).
3. Findlay, G. M., Boyle, E. A., Hause, R. J., Klein, J. C. & Shendure, J. Saturation editing of genomic regions by multiplex homologydirected repair. Nature 513, 120-123 (2014).
4. Zhou, Y. et al. High-throughput screening of a CRISPR/Cas9 library for functional genomics in human cells. Nature 509, 487-491 (2014).
5. Bikard, D. et al. Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials. Nat Biotechnol 32, 1146-1150 (2014).
6. Wu, X. et al. Genome-wide binding of the CRISPR endonuclease Cas9 in mammalian cells. Nat Biotechnol 32, 670-676 (2014).
7. Hsu, P. D., Lander, E. S. & Zhang, F. Development and applications of CRISPR-Cas9 for genome engineering. Cell 157, 1262-1278 (2014).
8. Barrangou, R. et al. Advances in CRISPR-Cas9 genome engineering: lessons learned from RNA interference. Nucleic Acids Res 43, 3407-3419 (2015).
9. Qi, L. S. et al. Repurposing CRISPR as an RNA-guided platform for sequence-specific control of geneexpression. Cell 152, 1173-1183 (2013).
10. Mali, P. et al. CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering. Nat Biotechnol 31, 833-838 (2013).
11. Zalatan, J. G. et al. Engineering complex synthetic transcriptional programs with CRISPR RNA scaffolds. Cell 160, 339-350 (2015).
12. Sternberg, S. H., Redding, S., Jinek, M., Greene, E. C. & Doudna, J. A. DNA interrogation by the CRISPR RNA-guided endonuclease Cas9. Nature 507, 62-67 (2014).
13. O'Connell, M. R. et al. Programmable RNA recognition and cleavage by CRISPR/Cas9. Nature 516, 263-266 (2014).
14. Yang, L. et al. Targeted and genome-wide sequencing reveal single nucleotide variations impacting specificity of Cas9 in human stem cells. Nat Commun 5, 5507 (2014).
15. Fu, Y. et al. High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. Nat Biotechnol 31, 822-826 (2013).
16. Fu, Y., Sander, J. D., Reyon, D., Cascio, V. M. & Joung, J. K. Improving CRISPR-Cas nuclease specificity using truncated guide RNAs. Nat Biotechnol 32, 279-284 (2014).
17. Doench, J. G. et al. Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9. Nat Biotechnol 34, 184-191 (2016).
18. Slaymaker, I. M. et al. Rationally engineered Cas9 nucleases with improved specificity. Science 351, 84-88 (2016).
19. Kleinstiver, B. P. et al. High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects. Nature 529, 490-495 (2016 ).
20. Rosenberg, U. B., Preiss, A., Seifert, E., Jäckle, H. & Knipple, D. C. Production of phenocopies by Krüppel antisense RNA injection into Drosophila embryos. Nature 313, 703-706 (1985).
21. Ma, M. et al. Intracellular mRNA cleavage induced through activation of RNase P by nuclease-resistant external guide sequences. Nat Biotechnol 18, 58-61 (2000).
22. Fire, A. et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391, 806-811 (1998).
23. Hale, C. R. et al. RNA-guided RNA cleavage by a CRISPR RNA-Cas protein complex. Cell 139, 945-956 (2009).
24. Price, A. A., Sampson, T. R., Ratner, H. K., Grakoui, A. & Weiss, D. S. Cas9-mediated targeting of viral RNA in eukaryotic cells. Proc Natl Acad Sci USA 112, 6164-6169 (2015).
25. Horwitz, E. et al. Human and mouse VEGFA-amplified hepatocellular carcinomas are highly sensitive to sorafenib treatment. Cancer Discov 4, 730-743 (2014).
26. Hua, D. et al. β 3GnT8 regulates laryngeal carcinoma cell proliferation via targeting MMPs/TIMPs and TGF-β 1. Asian Pac J Cancer Prev 13, 2087-2093 (2012).
27. Liu. Z. et al. Down-regulation of β -1,3-N-acetylglucosaminyltransferase-8 by siRNA inhibits the growth of human gastric cancer. Mol Med Rep. 4, 497-503 (2011).
28. Yang, Y., Kochoyan, M., Burgstaller, P., Westhof, E. & Famulok, M. Structural basis of ligand discrimination by two related RNA aptamers resolved by NMR spectroscopy. Science 272, 1343-1347 (1996).
29. Werstuck, G. & Green, M. R. Controlling gene expression in living cells through small molecule-RNA interactions. Science 282, 296-298 (1998).
30. Carey, J., Lowary, P. T. & Uhlenbeck, O. C. Interaction of R17 coat protein with synthetic variants of its ribonucleic acid binding site. Biochemistry 22, 4723-4730 (1983).
31. Suess, B. et al. Conditional gene expression by controlling translation with tetracycline-binding aptamers. Nucleic Acids Res 31, 1853-8 (2003).
32. Cao, L. et al. Osteopontin promotes a cancer stem cell-like phenotype in hepatocellular carcinoma cells via an integrin-NF- B-HIF- 1α pathway. Oncotarget 6, 6627-6640 (2015).
33. Lai, C. P. et al. Visualization and tracking of tumour extracellular vesicle delivery and RNA translation using multiplexed reporters. Nat Commun 6, 7029 (2015).
34. Hannus, M. et al. siPools: highly complex but accurately defined siRNA pools eliminate off-target effects. Nucleic Acids Res 42, 8049-8061 (2014).
35. Cho S. W. et al. Analysis of off-target effects of CRISPR/Cas-derived RNA-guided endonucleases and nickases. Genome Res 24, 132-141 (2014).
36. Ran F. A. et al. Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity. Cell 154, 1380-1389 (2013).
37. Shen, B. et al. Efficient genome modification by CRISPR-Cas9 nickase with minimal off-target effects. Nat Methods 11, 399-402 (2014).
38. Kennedy, A. B., Vowles, J. V., d'Espaux, L. & Smolke, C. D. Protein-responsive ribozyme switches in eukaryotic cells. Nucleic Acids Res 42, 12306-12321 (2014).
39. Nelles, D. A. et al. Programmable RNA Tracking in Live Cells with CRISPR/Cas9. Cell 165, 488-496 (2016).
40. Gao, Y. & Zhao, Y. Self-processing of ribozyme-flanked RNAs into guide RNAs in vitro and in vivo for CRISPR-mediated genome editing. Journal of integrative plant biology 56, 343-349 (2014).